covid 19 News and Research

RSS

Hospitalization for COVID-19 may increase the risk of later readmission or death

People who had been hospitalized for COVID-19 in 2020 - and survived for at least one week after discharge - were more than twice as likely to die or be readmitted to the hospital in the next several months compared to the general population, according to new research in PLOS Medicine.

26 Jan 2022

Online survey highlights the struggles of females with long COVID

Researchers assess the experiences and consequences of long COVID in women’s lives through an online intervention.

26 Jan 2022

Language used to describe 'long COVID' can impact patient outcomes

Researchers utilize an online experimental platform to explore the effect of different messages about long COVID on expectations of illness outcomes.

26 Jan 2022

Homologous and heterologous COVID-19 booster vaccines found to be safe and immunogenic

In adults who had previously received a full regimen of any of three COVID-19 vaccines granted Emergency Use Authorization (EUA) or approved by the U.S. Food and Drug Administration, an additional booster dose of any of these vaccines was safe and prompted an immune response, according to preliminary clinical trial results reported in The New England Journal of Medicine.

26 Jan 2022

More than 5,000 people enrolled in PANORAMIC study for COVID-19 antivirals

Over 5,000 vulnerable people have now enrolled into a world-class study for the chance to receive life-saving antivirals, the government has announced today (Wednesday 26 January 2022).

26 Jan 2022

Cross-recognition of SARS-CoV-2 vaccine-elicited T cell responses among different variants

In a new study, researchers evaluated SARS-CoV-2 vaccination-induced T cell responses cross-recognition among the early and novel SARS-CoV-2 variants.

26 Jan 2022

Antibodies against SARS-CoV-2 found to persist for up to 15 months after infection

In a new study, a team of researchers explored the association between total immunoglobulin (IgM, IgA, and IgG) against SARS-CoV-2 and protective immunity.

26 Jan 2022

Study suggests synthetic SARS-CoV-2 S glycoprotein coated lipid vesicles are an effective vaccine candidate

In a new study, a team of researchers developed a vaccine candidate with the SARS-CoV-2 spike (S) glycoprotein coated onto lipid vesicles which resembles virus-like particles.

26 Jan 2022

Alterations of sphingolipids and their metabolizing enzymes in hospitalized or convalescent COVID-19 patients

An interdisciplinary team of researchers from Europe analyzed the alterations of sphingolipids and their metabolizing enzymes in hospitalized or convalescent COVID-19 patients.

26 Jan 2022

Does remdesivir reduce mortality in moderately ill hospitalized patients with COVID-19?

A team of researchers performed a meta-analysis to investigate the use of remdesivir in the treatment of COVID-19.

26 Jan 2022

Exploring hematological alterations in COVID-19 patients

New study findings indicated that some hematological alterations that occur during COVID-19-related hospital admission were associated with an increase in the risk of COVID-19-associated ICU admission and mortality.

26 Jan 2022

Study demonstrates differential alternative splicing in betacoronaviruses

A new study investigates whether the proportion of ribosomal genes displaying differential gene expression and differential alternative splicing differed between three betacoronaviruses and six other viruses and bacteria.

26 Jan 2022

Study finds overexpression of 3 SARS-CoV-2 genes could globally compromise transcriptome of human pluripotent stem cell-derived cardiomyocytes

In a recent study, whole mRNA-seq was used to investigate the global effects of SARS-CoV-2 viral genes Nsp6, Nsp8, and M on the transcriptome of hPSC-CMs.

26 Jan 2022

SARS-CoV-2 Omicron variant found to display increased resilience to antiviral type I interferon response

In a new study, scientists have compared the Omicron variant with the Delta VOC (B.1.617.2) as well as the wildtype strain (B.1), with respect to their interaction with the antiviral type 1 interferon response in infected cells.

26 Jan 2022

Anti-SARS-CoV-2 antibodies found in wild mustelids in France

A new study focused on the identification of SARS-CoV-2 infection in wild mustelids in the French region of Brittany.

26 Jan 2022

Evaluating the use of megadoses of corticosteroids as a treatment of COVID-19

In a new study, researchers have been investigating the effects of megadoses of corticosteroids on hospitalized COVID-19 patients.

26 Jan 2022

How long does COVID-19 remain traceable on food?

In a new study, researchers identified the effective lengths at which SARS-CoV-2 can survive on certain foods, which can likely act as a model to predict how well it could survive on many others.

26 Jan 2022

DoD Awards Contract to Siemens Healthineers to Purchase COVID-19 Antigen Over-the-Counter Test Kits in Support of POTUS' 500 Million Free At-Home COVID-19 Tests

On Jan. 21, 2022, the Department of Defense (DoD) awarded a contract to Siemens Healthineers to procure 50 million over-the-counter COVID-19 test kits.

From Siemens Healthineers 26 Jan 2022

Test-negative case-control analysis during a Delta variant-dominant period in California’s prisons

A new study studies the waning of vaccine-conferred protection against SARS-CoV-2 infection, specifically the Delta variant, in two high-risk populations.

26 Jan 2022

COVID-19 vaccine does not lead to infertility in either men or women

In a recent prospective cohort study accepted to the American Journal of Epidemiology, researchers observed links between female and male coronavirus disease 2019 (COVID-19) vaccination and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and fecundability or the per-cycle likelihood of conception in North American couples seeking to conceive.

26 Jan 2022

covid 19 News and Research

Hospitalization for COVID-19 may increase the risk of later readmission or death

Online survey highlights the struggles of females with long COVID

Language used to describe 'long COVID' can impact patient outcomes

Homologous and heterologous COVID-19 booster vaccines found to be safe and immunogenic

More than 5,000 people enrolled in PANORAMIC study for COVID-19 antivirals

Cross-recognition of SARS-CoV-2 vaccine-elicited T cell responses among different variants

Antibodies against SARS-CoV-2 found to persist for up to 15 months after infection

Study suggests synthetic SARS-CoV-2 S glycoprotein coated lipid vesicles are an effective vaccine candidate

Alterations of sphingolipids and their metabolizing enzymes in hospitalized or convalescent COVID-19 patients

Does remdesivir reduce mortality in moderately ill hospitalized patients with COVID-19?

Exploring hematological alterations in COVID-19 patients

Study demonstrates differential alternative splicing in betacoronaviruses

Study finds overexpression of 3 SARS-CoV-2 genes could globally compromise transcriptome of human pluripotent stem cell-derived cardiomyocytes

SARS-CoV-2 Omicron variant found to display increased resilience to antiviral type I interferon response

Anti-SARS-CoV-2 antibodies found in wild mustelids in France

Evaluating the use of megadoses of corticosteroids as a treatment of COVID-19

How long does COVID-19 remain traceable on food?

DoD Awards Contract to Siemens Healthineers to Purchase COVID-19 Antigen Over-the-Counter Test Kits in Support of POTUS' 500 Million Free At-Home COVID-19 Tests

Test-negative case-control analysis during a Delta variant-dominant period in California’s prisons

COVID-19 vaccine does not lead to infertility in either men or women

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News